Magellan Health Inc
F:MAH1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (38.1), the stock would be worth €82.62 (1% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 38.5 | €83.5 |
0%
|
| 3-Year Average | 38.1 | €82.62 |
-1%
|
| 5-Year Average | 38.2 | €82.83 |
-1%
|
| Industry Average | 19.2 | €41.78 |
-50%
|
| Country Average | 19.6 | €42.59 |
-49%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| US |
M
|
Magellan Health Inc
F:MAH1
|
2.2B EUR | 38.5 | 8.5 | |
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
320.2B USD | 0 | 26.6 | |
| US |
A
|
Anthem Inc
LSE:0HG8
|
85.8B USD | 0 | 15.2 | |
| US |
|
Elevance Health Inc
NYSE:ELV
|
72.4B USD | 0 | 12.8 | |
| US |
|
Humana Inc
NYSE:HUM
|
26.2B USD | 0 | 22.1 | |
| US |
|
Centene Corp
NYSE:CNC
|
19.1B USD | 0 | -2.9 | |
| US |
|
Molina Healthcare Inc
NYSE:MOH
|
7.8B USD | 4.6 | 16.5 | |
| US |
|
Healthequity Inc
NASDAQ:HQY
|
7B USD | 23.2 | 32.7 | |
| BR |
|
Odontoprev SA
BOVESPA:ODPV3
|
8.5B BRL | 10.5 | 14.4 | |
| US |
|
Progyny Inc
NASDAQ:PGNY
|
1.5B USD | 12 | 25.2 | |
| US |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
1.2B USD | -13.8 | -15.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.6 |
| Median | 19.6 |
| 70th Percentile | 27.8 |
| Max | 1 826 183.2 |
Other Multiples
Magellan Health Inc
Glance View
In the world of healthcare innovation, Magellan Health Inc. has carved a notable niche, presenting a fresh compass in navigating complex healthcare systems. Founded with a keen focus on specialized management in the healthcare industry, Magellan Health has grown into a formidable player by providing comprehensive solutions in behavioral health, specialty healthcare, and pharmacy management. The company's journey is centered around bridging gaps within the healthcare system, offering services that address mental health and substance abuse issues, emphasizing its commitment to fostering holistic well-being. By managing these critical areas, Magellan partners with payers, providers, and public sector agencies, effectively orchestrating a network that alleviates the burden of mental health challenges and optimizes patient outcomes across the board. At its core, Magellan's financial engine hums through its innovative integration of managed care programs and technology-driven solutions. It generates revenue by offering tailored solutions that help reduce costs while improving access and outcomes. Through a mix of managed care plans for specialty populations and cutting-edge digital platforms, Magellan enhances the delivery of healthcare services, ensuring they reach those who need them most. The company's business model thrives on performance-based contracts and management fees, where success is measured by its ability to improve health care quality and efficiency. By continuously investing in technology and analytics, Magellan Health not only advances its core mission but also sustains a robust economic model that remains resilient amid evolving health sector dynamics.